CCPM collaborates with industry partners to accelerate research and advance personalized medicine. These partnerships allow CCPM and biobank participants to contribute to science and research conducted around the world. Any data contributed through these partnerships is de-identified so that no personal or identifying information on biobank participants is shared.
CCPM is partnering with Regeneron Genetics Center (RGC), a subsidiary of Regeneron Pharmaceuticals, to create a large-scale genomics database. The database will have de-identified genetic and clinical information from biobank participants and will be used to support research and discovery of genetic factors that could inform clinical care.
CCPM is collaborating with BC Platforms to support research and discovery. We are joining their ‘Global Data Partner Network’ (bcrquest.com). Through this partnership, CCPM will share de-identified clinical and genomic data from biobank participants via a secure platform that is used by researchers and pharmaceutical companies around the world.
"Our partnerships will help drive the health care discoveries of tomorrow and realize the full potential of precision medicine. We so appreciate our patients who have consented to participate and without whom discovery would not be possible.”
– Richard Zane, MD
UCHealth Chief Innovation Officer, Professor and Chair, Department of Emergency Medicine, CU School of Medicine